Sligo based Hawk's Rock Distillery announces first release since recent re-brand
The Sazerac Company, one of the world's largest distilled spirits companies, is celebrating the release of its inaugural Irish whiskey from Hawk's Rock Distillery: Garavogue 20 Year Old Single Malt Irish Whiskey.
Crafted by Master Blender Helen Mulholland, the first female Master Blender in Irish Whiskey history, this new-to-world whiskey brand embodies Sazerac's dedication to world class distillation, aging and blending.
Named after the Garavogue River that flows through Sligo town, Garavogue Whiskey is a bridge between past and present, honouring the rich traditions of Irish whiskey while embracing innovation and discovery.
Every small-batch release under the Garavogue name will be limited and experimental in nature, exploring different ages, maturation techniques and possibly even different types of Irish whiskey.
For its inaugural and limited release expression, Garavogue 20-Year-Old Single Malt Irish Whiskey offers a rare take on traditional Irish Whiskey with both unexpected and familiar flavours due to its unique maturation involving multiple types of casks.
Double-distilled and initially aged for a minimum of 14 years in ex-bourbon American oak casks, the whiskey was then transferred into a variety of unique finishing casks including French Muscat, French Sauternes, Spanish Pedro Ximénez Sherry and Barbadian Rum casks for further maturation.
The result is a 94-proof whiskey with aromas of vanilla, warm peach, and spun sugar from the Sauternes cask influence, while floral and raisin notes from the Muscat and Sherry casks emerge on the nose.
On the palate, vanilla and citrus sweetness complement buttery ripe apples, while fresh fruit flavours from the rum cask create a prominent sweet finish.
'The current trend is for whiskey to have a rich sherry finish, but Garavogue is purposefully different,' says Master Blender Helen Mulholland.
'We believe that complexity and subtlety can work hand in hand.
ADVERTISEMENT
'It is unusual for a whiskey to be blended with this number and variety of casks, but just as the river ebbs and flows, the flavours create a wonderful blend as they weave together in this 20-year-old single malt.'
Release #1 is housed in a distinctive reversed crescent shape bottle with a blue label reflecting the Garavogue River's influence including subtle wave patterns that mirror the motion of water.
The label also features imagery and coordinates for the Hazelwood House Windmill – an enduring landmark on the grounds of Hawk's Rock – in tribute to the historical figures who lived and worked along the Garavogue's banks.
'We hope that Garavogue Whiskey invites Irish Whiskey fans to linger, explore and uncover the hidden stories of Sligo,' remarks Jess Scheerhorn, Vice President at Sazerac. 'The Garavogue River shaped this beautiful landscape for millenniums, and Garavogue Irish Whiskey aims to shape new experiences, connections and traditions – one sip at a time.'
Garavogue Whiskey will be available at a suggested retail price of €199 (700ML) in limited quantities through Sazerac's distributor networks across the United States, Ireland, United Kingdom and Duty-Free.
A limited supply will also be available for purchase directly via Legacy de Forge, a new Sazerac branded global platform powered by Blockbar for purchasing some of the world's most coveted bottles.
Please visit www.LegacydeForge.com for more information.
Garavogue Whiskey is the first release from Sazerac's recently rebranded Hawk's Rock Distillery, which is named after a prominent outcrop in the Ox Mountains known for inspiring Nobel Prize winning poet William Butler (W.B.) Yeats, who called Sligo his 'spiritual home.'
In April 2025, Hawk's Rock owner, Sazerac Company, announced the renaming of Hawk's Rock Distillery from Lough Gill Distillery, referring to the name change as a reflection of the company vision for the future – blending curiosity, innovation and respect for Sligo's heritage.
For more information, please visit hawksrockdistillery.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Journal
4 hours ago
- The Journal
Quiz: How well do you know the support acts of Slane's biggest concerts?
LORD HENRY MOUNT Charles, best known for staging huge concerts at his home at Slane Castle in Meath , died on Wednesday aged 74. The driving force behind turning the Meath estate into the location that played host to acts such as U2, Queen, David Bowie and the Rolling Stones died following a long battle with cancer. Advertisement Slane has become a byword for iconic Irish concerts over the past four decades thanks to Mount Charles – and as such, many of the concerts have boasted some very well-known and talented support acts. So, we wanted to ask you – how well do you know these support acts of Slane Castle's biggest concerts? The first Slane Castle concert was held in 1981, headlined by Thin Lizzy. What other Irish band famously featured as a support act? Alamy Stock Photo The Undertones U2 The Boomtown Rats The Waterboys A 1982 Rolling Stones concert at Slane featured three support acts - including the J. Geils Band and the Chieftains. What was the name of the other support band? Alamy Stock Photo George Thorogood and the Destroyers Jack Cannon and the Reckoners Ricky Wooledge and the Outlaws Danny Brugos and the Wildfires Who was the main support for Queen's 80,000 sellout performance at Slane? Alamy Stock Photo Eric Clapton Mark Knopfler Chris de Burgh Chris Rea Neil Young's 1993 concert at Slane Castle boasted an all-star support line-up. Which of these bands was NOT a support act? Alamy Stock Photo Pearl Jam Van Morrison Saw Doctors The Cranberries Sharon Shannon and Spearhead joined REM for their Slane gig in 1993. What burgeoning British band also featured as a support act? Alamy Stock Photo Oasis Blur Radiohead The Stone Roses The Verve played the popular Meath location in 1998. Which of their support acts would go on to headline Slane the following year? Alamy Stock Photo Manic Street Preachers Finley Quaye Robbie Williams James U2 headlined the iconic venue twice in the space of a week in 2001. Who was their support act for the first gig? Alamy Stock Photo The White Stripes Red Hot Chili Peppers The Strokes Backstreet Boys ... and who was the support for their second gig? Faithless Groove Armada Air Moby Which singer did not feature any support acts at their 2005 concert? Rolling News Madonna Kylie Minogue Britney Spears Mariah Carey In 2011, Kings of Leon graced the Slane stage. Which previous headliner returned to feature as a support act for them? Alamy Stock Photo U2 Thin Lizzy Red Hot Chilli Peppers Stereophonics Bon Jovi played there in June 2013. Which of these food-themed bands played support? Alamy Stock Photo Smashing Pumpkins The Cranberries Ham Sandwich Bowling for Soup Metallica played Slane in 2019 - who was their main support act? Alamy Stock Photo Mastodon Ghost Rammstein Volbeat The most recent concert to grace the historic location was headlined by British pop icon Harry Styles. Which Irish DJ featured among the support acts? Alamy Stock Photo Annie Mac Shane Codd Krystal Klear ELLLL Answer all the questions to see your result! Rolling News You scored out of ! Slane veteran You've been to your fair share of gigs Share your result: Share Tweet Rolling News You scored out of ! You know your stuff You've definitely been to Slane Castle before Share your result: Share Tweet Rolling News You scored out of ! A decent attempt Time to get to more gigs! Share your result: Share Tweet Rolling News You scored out of ! Concert newbie You've heard of Slane, right? Share your result: Share Tweet Rolling News You scored out of ! You got nothing Concerts aren't for everyone Share your result: Share Tweet Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal
Irish Examiner
5 hours ago
- Irish Examiner
John Whelan: Ireland behind the curve in pharma R&D amid Pfizer call
Pharma companies met with the Trump administration earlier this month to try and defer implementation of the executive order signed by President Trump on May 12, effectively forcing drug companies to commit to aligning their US prices with 'the lowest price of a set of economic peer countries''. At the meeting of the Pharmaceutical Research and Manufacturers of America (PhRMA) with the Trump administration, Pfizer chief executive Albert Bourla called for the US government to lead an initiative to increase overall drug spending outside the US. While the exact mechanism of implementing the Trump executive order to reduce drug prices in the US remains unclear, the Pfizer chief proposed an alternative solution, suggesting that other countries should spend a certain percentage of their GDP per capita on innovative medicines. In an attempt to lead on the recommendation, he added that Pfizer could consider not making its drugs available for government reimbursement in some countries if the US carries through on its price control and other countries don't increase their prices. Effectively, Mr Bourla, who chairs the pharma industry lobby group PhRMA, suggested the US should push for a Nato-type agreement, which commits each country to a minimum 2% of their national GDP on defence spending. And whereas there may be good logic in the Pfizer proposal, any commitment of this nature will likely create major challenges for Ireland, as OECD and World Bank figures show Ireland lagging well behind other countries in research and development expenditure. In 2022, the last year for which finalised figures have been released, US pharmaceutical companies' R&D spending amounted to 2.33% of the nation's GDP. There is no comparable figures for the Irish market, in terms of pharmaceutical industry expenditure in research and development. However, the figures available from the World Bank and the OECD for years 2022/2023 show that total R&D for all industry as a percentage of GDP, in Ireland was 0.9%. This is well below the EU average of 2.29%, and even further below countries like the US at 3.6% and Israel at 6.3% who invest more heavily in R&D than Ireland. Economists have inferred that Trump is leveraging unfavourable policies such as drastically lowering prices points of US drugs and tariffs on imports, to coerce the pharmaceutical industry to increase investments in the US. Several large pharma companies, including Eli Lilly, Merck & Co, and Bristol Myers Squibb, have unveiled major US investments planned for the next few years in attempt to curry favour with the Trump administration. But noticeably Pfizer remains an exception to that trend. However, Mr Bourla stated that Pfizer has invested in US manufacturing and will continue to do so, but risks from those Trump policies are making it difficult for the company to commit further. "I don't think it makes sense to make announcements of future investments in an environment that is very fluid,' Mr Bourla said. That suggests Pfizer, one of our largest and longest-term investors in the pharmaceuticals space, is unlikely to back off its Irish investments anytime soon. However , we need to heed the Pfizer CEO's call for more R&D support in Europe, which clearly includes Ireland. Besides Pfizer, many pharma companies are leveraging the United States' threat of tariffs on drug imports to push for policy changes in the EU. In a letter sent on April 11 to European Commission President Ursula von der Leyen, 32 pharma companies demanded more favourable policies in order for them to maintain operations in the EU . In the same letter they say that policy changes are needed to ensure Europe remains a location to research, develop, and manufacture medicines. The CEOs also included in their letter that European countries should rethink their drug pricing policies and enable a better commercial environment for innovative medicines. Ireland's Research and Innovation Act 2024 , replaces Science Foundation Ireland in an attempt to fast forward the provision for the funding of research and innovation, but this caters for all fields of activity and neither commits to double the level of funding to €2bn per year needed to reach EU level, nor does it commit to meet the specific requirements of the pharma industry.
Irish Examiner
5 hours ago
- Irish Examiner
Infrastructure taskforce to be updated on project delays
The Government's recently-formed infrastructure taskforce is to be briefed on the delays besetting key projects across the country. Public expenditure minister Jack Chambers is to chair the second meeting of the 'accelerating infrastructure taskforce', which is focusing on removing barriers to delivery. At the meeting, it is expected that members will be briefed on specific projects that have been subject to different types of delay. This will include the M28 Ringaskiddy-to-Cork road, alongside water and energy projects across the country. One government source said taskforce members will examine what changes to current processes and project requirements could be made to 'strike the appropriate balance between the controls and procedures governing the delivery of major capital projects'. It is understood the taskforce will submit a report that identifies the specific barriers to infrastructure delivery to the Government by the end of July. It comes after one member of the taskforce, Economic and Social Research Institute chairman Sean O'Driscoll, told the Irish Examiner there were 'catastrophic consequences' facing Ireland's water, energy, and transport networks if 'radical and brave decisions are not taken to ensure projects get completed quicker'. Mr O'Driscoll said the Government needed to accept that there is a 'national crisis' in Irish infrastructure, while adding that public servants are more 'scared' of the public accounts committee than the economy declining. Meanwhile, Taoiseach Micheál Martin is to bring an update on the Government's expert group on conveyancing and probate, with the group set to be extended for a further six months. The group is recommending a more permanent structure to take over dealing with issues surrounding probate and conveyancing in December. Conveyancing and probate are the legal processes for transferring a property from one person to another, or for when an individual dies. The Government's aim through the group is to speed up the conveyancing and probate processes, to avoid houses being left empty due to being stuck in lengthy processes. There is a target of an eight-week turnaround time for solicitors to complete conveyancing, from the acceptance of an offer to its close. A new e-probate system is expected to be launched later this year, which the Government believes will significantly reduce processing times and delays. The group is continuing to develop proposals around the establishment of an e-conveyancing system over the coming six months. Cabinet will also be briefed around the implementation of the Dublin City taskforce report. It is understood that proposals within the implementation plan include the establishment of a development body for regeneration projects in the city. This would include the future use of the GPO on O'Connell Street, but would also look at regenerating shops, apartments, and offices within the city. Elsewhere, a meeting between transport minister Darragh O'Brien and justice minister Jim O'Callaghan took place last week to discuss options for the establishment of a new transport police. It is understood that any such force would operate outside An Garda Síochána and would not be under the remit of the Department of Justice. Government sources indicated that the current preferred model would see the transport police led by the National Transport Authority, with powers similar to that of the airport police.
